Contribution: Industrial Research Assistance Program – Contributions to Firms
Tevosol Inc.
$232,500.00
Subsystem Level Proof of Concept Design and Engineering of the clinical EVOSS Lung
FY 2018-19 · 2018-08-01
Summary
Tevosol has developed and tested a normothermic organ perfusion system for preserving and assessing organs recovered for transplant. This project will build on the previous Device Definition work to engineer subsystem-level prototypes to de-risk critical elements of the device architecture, in advance of an integrated Proof of Concept prototype which will be a subsequent project.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
821124799
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-08-01 | 2018-19 | $232,500.00 |
| 1 | 2018-08-01 | 2018-19 | $232,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 31 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 31 jours.
Agreement End Date
2019-05-31
Agreement Number
911378
Agreement Start Date
2018-08-01
Agreement Title
Subsystem Level Proof of Concept Design and Engineering of the clinical EVOSS Lung
Agreement Title (French)
Démonstration de faisabilité du sous-système de conception et ingénierie de poumon clinique EVOSS
Agreement Type
Contribution
Agreement Value
$232,500.00
Amendment Date
2019-02-13
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Tevosol has developed and tested a normothermic organ perfusion system for preserving and assessing organs recovered for transplant. This project will build on the previous Device Definition work to engineer subsystem-level prototypes to de-risk critical elements of the device architecture, in advance of an integrated Proof of Concept prototype which will be a subsequent project.
Description (French)
Tevosol a développé et testé un système de perfusion d'organes normothermiques pour préserver et évaluer les organes récupérés en vue d'une transplantation. Ce projet s’appuiera sur le précédent travail de définition de dispositif pour concevoir des prototypes au niveau du sous-système afin de réduire les risques liés aux éléments critiques de l’architecture du dispositif, avant un prototype intégré de validation de projet.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
33451
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
821124799
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
Tevosol Inc.
Recipient Postal Code
T5J 4P6
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2018-2019-Q2-911378
